Rory Fisher, PhD
Introduction
Molecular Biology and Signaling of RGS Proteins Cells communicate with the outside world by interactions of molecules with receptors that activate signal transduction pathways, thereby converting extracellular messages into cellular responses. Various hormones, neurotransmitters, autacoids and sensory molecules activate a family of seven- transmembrane-domain receptors that specifically couple to heterotrimeric G proteins, activating specific second messenger systems.. This signaling system is extremely common and important (e.g., the senses of vision, smell and taste all work by these mechanisms), controlling exceptionally diverse physiological and pathophysiological processes. GPCRs and their signaling components enable cells to adjust to their environment rapidly and with exquisite sensitivity and precision. More than half of known drugs target components of this indispensable signaling system in humans. The intensity and duration of G protein signaling via heterotrimeric G proteins is regulated at multiple levels. Recently, a new gene family (RGS proteins) was identified that provides new insights into how G proteins are turned off once activated by receptors. RGS proteins are key negative regulators of G protein signaling by virtue of their GTPase-activating protein (GAP) activity toward G protein subunits. Our laboratory has pioneered the idea that RGS proteins possess activities apart from or in addition to those involved in G protein signaling. Molecular cloning and characterization of new members of the RGS family in our lab revealed surprising diversity in regions not associated with their GAP activity. These and other findings, including evidence that most RGS proteins traffick to and from the nucleus, raised the intriguing possibility that RGS proteins might possess diverse functional activities. In our studies, we have characterized the role of RGS proteins in G protein signaling and determined mechanisms underlying their unique subcellular trafficking in cells, gaining new insights into structural/functional relationships of RGS proteins. We identified the structural organization of genes encoding numerous RGS proteins, revealing exceptional complexity in splicing of some RGS protein transcripts (e.g., 36 splice forms of RGS6) and facilitating gene knock-in and knock-out studies (functional genomics) to determine the role of these proteins in organisms. Our recent studies have revealed novel signaling functions of RGS proteins in the nucleus, in neuronal differentiation and development, and in DNA damage signaling responses. We identified an RGS polymorphism (gene variant) in humans associated with a significant reduction in the risk of cancer, providing the first link between RGS protein expression and cancer. These studies raise questions of considerable interest and importance concerning the role of RGS proteins in cellular regulation by mechanisms both dependent on and independent of their regulatory actions on G proteins. Some current projects include identifying novel RGS protein interaction partners, anti-sense and transgene technologies to probe physiological roles of RGS proteins, defining the role of nuclear RGS proteins and determining the mechansims regulating RGS gene expression.
Current Positions
- Professor of Neuroscience and Pharmacology
- Professor of Internal Medicine
- Director of Graduate Studies, Department of Neuroscience and Pharmacology
Education
- Texas A&M University, College Station, Texas
- BS in Biology, Rockford College, Rockford, Illinois
- PhD in Molecular Cellular Development Biology, Dept. of Biochemistry & Biophysics, Iowa State University, Ames, Iowa
- Postdoctoral Fellow in Pathology, University of Texas Health Science Center, San Antonio, Texas
- Postdoctoral Fellow in Biochemistry, University of Texas Health Science Center, San Antonio, Texas
Graduate Program Affiliations
Center, Program and Institute Affiliations
Research Interests
- Research Interest - RGS proteins and heterotrimeric G Protein signaling
- Current Projects
Selected Publications
- Ahlers-Dannen, K. E., Spicer, M. M. & Fisher, R. A. (2020). RGS proteins as critical regulators of motor function and their implications in Parkinson's disease. Molecular pharmacology pii: mol.119.118836. DOI: 10.1124/mol.119.118836. PMID: 32015009.
- Perschbacher, K. J., Deng, G., Sandgren, J. A., Walsh, J. W., Witcher, P. C., Sapouckey, S. A., Owens, C. E., Zhang, S. Y., Scroggins, S. M., Pearson, N. A., Devor, E. J., Sebag, J. A., Pierce, G. L., Fisher, R. A., Kwitek, A. E., Santillan, D. A., Gibson-Corley, K. N., Sigmund, C. D., Santillan, M. K. & Grobe, J. L. (2019). Reduced mRNA Expression of RGS2 (Regulator of G Protein Signaling-2) in the Placenta Is Associated With Human Preeclampsia and Sufficient to Cause Features of the Disorder in Mice. Hypertension 75 (2) 569-579. DOI: 10.1161/HYPERTENSIONAHA.119.14056. PMID: 31865781. PMCID: PMC7027931 [Available on 2021-02-01].
- Cunningham, I., Hamele-Bena, D., Guo, Y., Shiomi, T., Papp, A. C., Chakravarti, B., Yang, J., Shyr, Y. & Fisher, R. A. (2019). Extramedullary leukemia behaving as solid cancer: clinical, histologic, and genetic clues to chemoresistance in organ sites. American journal of hematology 94 (11) 1200-1207. DOI: 10.1002/ajh.25594. PMID: 31353508.
- Luo, Z., Ahlers-Dannen, K. E., Spicer, M. M., Yang, J., Alberico, S., Stevens, H. E., Narayanan, N. S. & Fisher, R. A. (2019). Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice. JCI Insight 5 pii: 126769. DOI: 10.1172/jci.insight.126769. PMID: 31120439. PMCID: PMC6629243.
- Perschbacher, K. J., Deng, G., Fisher, R. A., Gibson-Corley, K. N., Santillan, M. K. & Grobe, J. L. (2018). Regulators of G-Protein Signaling in Cardiovascular Function During Pregnancy. Physiological genomics. DOI: 10.1152/physiolgenomics.00037.2018. PMID: 29702036.
- Chakravarti, B., Yang, J., Ahlers-Dannen, K. E., Luo, Z., Flaherty, H. A., Meyerholz, D. K., Anderson, M. E. & Fisher, R. A. (2017). Essentiality of Regulator of G Protein Signaling 6 and Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II in Notch Signaling and Cardiovascular Development. Journal of the American Heart Association 6 (11). DOI: 10.1161/JAHA.117.007038. PMID: 29079565. PMCID: PMC5721783.
- Yang, J., Platt, L. T., Maity, B., Ahlers, K. E., Luo, Z., Lin, Z., Chakravarti, B., Ibeawuchi, S. R., Askeland, R. W., Bondaruk, J., Czerniak, B. A. & Fisher, R. A. (2016). RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation. Oncotarget 7 (43) 69159-69172. DOI: 10.18632/oncotarget.12473. PMID: 27713144. PMCID: PMC5342467.
- Rorabaugh, B. R., Chakravarti, B., Mabe, N. W., Bui, A., Yang, J., Watts, S. W., Neubig, R. R., Fisher, R. A. & Seeley, S. L. (2016). Regulator of G Protein Signaling 6 (RGS6) Protects the Heart from Ischemic Injury. Am J Physiol Heart & Circ Physiol 360 (3) 409-416. PMID: 28035008. DOI: 10.1124/jpet.116.238345.
- Ahlers, K. E., Chakrvarti, B. & Fisher, R. A. (2016). RGS6 as a novel therapeutic target in CNS diseases and cancer. AAPS J 18 (3) 560-72. PMID: 27002730. PMCID: PMC Journal - in process.
- Stewart, A., Maity, B., Anderegg, S. P., Allamargot, C., Yang, J. & Fisher, R. A. (2015). Regulator of G protein signaling 6 is a critical mediator of both reward-related behavioral and pathological responses to alcohol. Proceedings of the National Academy of Sciences of the United States of America 112 (7) E786-95. DOI: 10.1073/pnas.1418795112. PMID: 25646431. PMCID: 4343156.